It has been reported that TFAP2A can be involved in the EMT process in multiple ways, for example, by binding of TFAP2A to the TGFB1 promoter in HCCC cholangiocarcinoma cell lines [32, 33]. The gene discussed is TFAP2A; the disease is cholangiocarcinoma.